We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00734890
First Posted: August 14, 2008
Last Update Posted: March 16, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Cancer Institute (NCI)
Information provided by:
National Institutes of Health Clinical Center (CC)